We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership to Simplify Complex DNA Microarray Analyses

By LabMedica International staff writers
Posted on 14 Jul 2011
A partnership between American and British biotech companies will automate and simplify the complex and error-prone manual steps previously required for performing DNA microarray analyses.

BlueGnome (Cambridge, United Kingdom) has announced the signing of a supply agreement with SciGene (Sunnyvale, CA, USA). More...
SciGene will manufacture BlueGnome’s new range of ClearHyb hybridization and wash systems.

Previously SciGene had noted that BlueGnome’s recommended manual labeling, hybridization, and posthybridization processing methods for its CytoChip test required a collection of laboratory equipment and supplies including staining dishes, slide boxes, stirrers, Coplin jars, a water bath, and an oven that need to be collected, cleaned, and assembled for each run. Once set up, the procedure was technically challenging with many handling steps including the use of seven different washes with careful monitoring of buffer temperatures. The complexity of the methods provided multiple entry points for variability that could lead to ambiguous patient results and a higher cost per test.

The new partnership was designed to eliminate this ambiguity by automating and simplifying the complex and error-prone manual steps from sample preparation through slide processing for improved test reliability and lowered cost.

Nick Haan, CEO of BlueGnome, said, “Time to market is a major issue for new laboratories that wish to establish and evolve their microarray-based services. With sales to 39 countries so far this year, we find that new laboratories are increasingly looking for a complete turnkey solution, including laboratory hardware, which enables their newly trained scientists to deliver the highest quality results in the shortest possible timeframe. We have long recommended SciGene products as the best available solution for hybridization and washing of our microarrays and are excited to be working with them to strengthen this relationship with new ClearHyb products.”

Dr. Jim Stanchfield, president and CEO of SciGene, said, “We are pleased with our partnership whereby SciGene technology will be used to simplify the microarray workflow used with BlueGnome’s array solutions that will enhance the reproducibility of these assays and their customers’ laboratory productivity.”

Related Links:
BlueGnome
SciGene


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.